We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+30.91%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.29B
AUM Growth
+$94.4M
Cap. Flow
-$78.5M
Cap. Flow %
-6.1%
Top 10 Hldgs %
48.93%
Holding
207
New
56
Increased
31
Reduced
35
Closed
51

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$30.6M
2
QURE icon
uniQure
QURE
+$18.4M
3
NVRO
NEVRO CORP.
NVRO
+$16.5M
4
TVTX icon
Travere Therapeutics
TVTX
+$12.9M
5
ARAV
Aravive, Inc. Common Stock
ARAV
+$12M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$34.8M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$21.8M
3
ESPR
Esperion Therapeutics
ESPR
+$19.5M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$19.3M
5
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 84.11%
2 Miscellaneous 14.93%
3 Consumer Staples 0.85%
4 Technology 0.05%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTEM
176
DELISTED
Molecular Templates, Inc.
MTEM
– –
-970
Closed -$509K
ISEE
177
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-429,386
Closed -$19.3M
ABMD
178
CALL
DELISTED
Abiomed Inc
ABMD
– –
-50,000
Closed -$1.9M
CLVS
179
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-5,138
Closed -$288K
EPZM
180
DELISTED
Epizyme, Inc
EPZM
– –
-432,619
Closed -$8.16M
BSTC
181
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-6,065
Closed -$234K
BFYT
182
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
– –
-96,000
Closed -$687K
ACHN
183
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-106,100
Closed -$1.3M
CIVI
184
DELISTED
Civitas Solutions, Inc.
CIVI
– –
-13,585
Closed -$231K
KERX
185
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-200,000
Closed -$2.83M
JUNO
186
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-50,000
Closed -$2.61M
SCLN
187
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
– –
-29,942
Closed -$262K
ALR
188
DELISTED
Alere Inc
ALR
– –
-98,000
Closed -$3.72M
PRXL
189
DELISTED
Parexel International Corp
PRXL
– –
-4,005
Closed -$223K
SPNC
190
DELISTED
Spectranetics Corp
SPNC
– –
-16,335
Closed -$565K
ELOS
191
DELISTED
Syneron Medical Ltd
ELOS
– –
-152,609
Closed -$1.42M
NSPH
192
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-35,378
Closed -$277K
CYBX
193
DELISTED
CYBERONICS INC
CYBX
– –
-4,454
Closed -$248K
SKH
194
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
– –
-31,293
Closed -$268K
VBLX
195
DELISTED
VASCULAR BIOGENICS LTD ORD SHS (ISR)
VBLX
– –
-500,000
Closed -$2.96M
RXII
196
PUT
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-200,000
Closed -$302K
PDLI
197
DELISTED
PDL BioPharma, Inc.
PDLI
– –
-30,151
Closed -$232K
BDSI
198
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-605,407
Closed -$7.28M
BCR
199
DELISTED
CR Bard Inc.
BCR
– –
-1,367
Closed -$228K
AGN
200
DELISTED
Allergan Inc
AGN
– –
-82,583
Closed -$17.6M
4 5 6 7
8

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Perceptive Advisors held 207 positions worth $1.29B, up 7.9% from $1.19B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Perceptive Advisors withdrew a net $78.5M in Q1 2015, closing 51 positions and reducing 35 holdings. Its most notable exit was PTC Therapeutics, an estimated $34.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 80% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Iovance Biotherapeutics worth $32.9M.

  • Perceptive Advisors's largest Q1 2015 buy was Iovance Biotherapeutics: 2,714,549 shares worth $32.9M.
  • Perceptive Advisors added most to uniQure in Q1 2015, an estimated $18.4M increase.
  • Perceptive Advisors's biggest Q1 2015 reduction was RECEPTOS INC COM STK (DE), cutting an estimated $21.8M.
  • Perceptive Advisors fully exited PTC Therapeutics in Q1 2015, selling an estimated $34.8M.
  • Perceptive Advisors's ten largest holdings make up 49% of its $1.29B portfolio in Q1 2015.
  • Perceptive Advisors opened 56 new positions and closed 51 in Q1 2015.
  • Perceptive Advisors's portfolio value rose 7.9% quarter-over-quarter to $1.29B.

Based on Perceptive Advisors's 13F filing for Q1 2015, filed 15 May 2015.